-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's After-Market Session
Share
Listen to the news

Gainers

  • Vivos Therapeutics (NASDAQ:VVOS) stock increased by 17.9% to $0.16 during Monday's after-market session. The market value of their outstanding shares is at $2.8 million.
  • SCWorx (NASDAQ:WORX) shares moved upwards by 10.78% to $2.97.
  • Metagenomi Therapeutics (NASDAQ:MGX) stock rose 9.63% to $0.89. The market value of their outstanding shares is at $31.9 million.
  • TScan Therapeutics (NASDAQ:TCRX) shares increased by 8.75% to $0.23. The market value of their outstanding shares is at $16.2 million.
  • Karyopharm Therapeutics (NASDAQ:KPTI) shares increased by 7.65% to $0.37. The market value of their outstanding shares is at $7.9 million.
  • Neumora Therapeutics (NASDAQ:NMRA) stock rose 7.29% to $0.5. The company's market cap stands at $80.2 million.

Losers

  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock decreased by 42.5% to $0.06 during Monday's after-market session.
  • Quest Diagnostics (NYSE:DGX) stock declined by 12.78% to $204.9. The company's market cap stands at $26.3 billion.
  • Enlivex (NASDAQ:ENLV) shares fell 7.62% to $0.19. The company's market cap stands at $4.4 million.
  • Bio Green Med Solution (NASDAQ:BGMS) stock fell 6.75% to $0.87. The company's market cap stands at $5.5 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) shares declined by 6.67% to $0.11. The market value of their outstanding shares is at $2.8 million.
  • Scienture Holdings (NASDAQ:SCNX) stock decreased by 5.83% to $2.75. The company's market cap stands at $5.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending